80 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Biosimilar Remove Biosimilar filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
Date of authorisation: 08/05/2017,
, 
, 
, Revision: 7, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
Date of authorisation: 08/09/2015,, , , Revision: 5, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Remsima (updated)
Date of authorisation: 10/09/2013,
, Revision: 17, Authorised, Last updated: 05/12/2019
-
List item
Human medicine European public assessment report (EPAR): Foclivia (updated)
Date of authorisation: 18/10/2009,, Revision: 9, Authorised, Last updated: 04/12/2019
-
List item
Human medicine European public assessment report (EPAR): Ziextenzo (updated)
Date of authorisation: 22/11/2018,, , Revision: 1, Authorised, Last updated: 04/12/2019
-
List item
Human medicine European public assessment report (EPAR): Mepsevii (updated)
Date of authorisation: 23/08/2018,, , , Revision: 3, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq (updated)
Date of authorisation: 28/08/2015,, , , Revision: 10, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Udenyca (updated)
Date of authorisation: 21/09/2018,, , Revision: 3, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kanjinti (updated)
Date of authorisation: 16/05/2018,, , Revision: 6, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
Date of authorisation: 16/11/2011,, , , Revision: 15, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Pelgraz (updated)
Date of authorisation: 21/09/2018,, , Revision: 4, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Rixathon (updated)
Date of authorisation: 15/06/2017,, , Revision: 3, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Atriance (updated)
Date of authorisation: 22/08/2007,, , , Revision: 21, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Elaprase (updated)
Date of authorisation: 08/01/2007,, , , Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, , , Revision: 5, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Erelzi (updated)
Date of authorisation: 23/06/2017,, , Revision: 5, Authorised, Last updated: 21/11/2019
-
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
Date of authorisation: 20/11/2018,, , Revision: 2, Authorised, Last updated: 21/11/2019
-
List item
Human medicine European public assessment report (EPAR): Pelmeg (updated)
Date of authorisation: 20/11/2018,, , Revision: 2, Authorised, Last updated: 20/11/2019
-
List item
Human medicine European public assessment report (EPAR): Benepali (updated)
Date of authorisation: 13/01/2016,, , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
Date of authorisation: 18/10/2013,, , , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Zirabev (updated)
Date of authorisation: 14/02/2019,, , Revision: 2, Authorised, Last updated: 18/11/2019
-
List item
Human medicine European public assessment report (EPAR): Mvasi (updated)
Date of authorisation: 15/01/2018,, , Revision: 5, Authorised, Last updated: 12/11/2019
-
List item
Human medicine European public assessment report (EPAR): Hulio (updated)
Date of authorisation: 16/09/2018,, , Revision: 3, Authorised, Last updated: 11/11/2019
-
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
Date of authorisation: 10/10/2009,, Revision: 10, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Binocrit
Date of authorisation: 28/08/2007,, Revision: 20, Authorised, Last updated: 31/10/2019